Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.

PLoS One · 2011 · PMC3121773 · PMID 21731744

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the association between membrane BCRP/ABCG2 expression and the best response to gefitinib did not reach statistical significance, the group with negative membrane BCRP/ABCG2 expression showed a higher percentage of stable disease and partial response ( Table S2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.